RLAY - Relay Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RLAY is currently covered by 10 analysts with an average price target of $24.73. This is a potential upside of $6.85 (38.31%) from yesterday's end of day stock price of $17.88.

Relay Therapeutics's activity chart (see below) currently has 138 price targets and 126 ratings on display. The stock rating distribution of RLAY is 10.34% HOLD and 89.66% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 39.23% with an average time for these price targets to be met of 246.04 days.

Highest price target for RLAY is $31, Lowest price target is $18, average price target is $24.73.

Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 20-Aug-2026. First documented stock forecast 10-Aug-2020.

Currently out of the existing stock ratings of RLAY, 3 are a HOLD (10.34%), 26 are a BUY (89.66%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 05-Nov-2020

$29

$11.12 (62.19%)

$28

1 months 22 days ago
(20-Aug-2026)

15/29 (51.72%)

$9.3 (47.21%)

523

Buy Since 08-Jul-2026

$31

$13.12 (73.38%)

$28

1 months 28 days ago
(14-Aug-2026)

0/2 (0%)

$11.14 (56.09%)

Buy Since 08-Dec-2020

$26

$8.12 (45.41%)

$21

2 months 2 days ago
(10-Aug-2026)

5/19 (26.32%)

$6.06 (30.39%)

180

Buy Since 08-Apr-2026

$30

$12.12 (67.79%)

$27

2 months 5 days ago
(07-Aug-2026)

0/3 (0%)

$10.23 (51.75%)

Buy Since 10-Aug-2020

$31

$13.12 (73.38%)

$22

2 months 21 days ago
(21-Jul-2026)

2/5 (40%)

$11.7 (60.62%)

575

Show more analysts

Please expand the browser size to see the chart

What is RLAY (Relay Therapeutics) average time for price targets to be met?

On average it took 246 days for the stock forecasts to be reached, with an average price target met ratio of 39.23%.

Which analyst most recently updated their price target on RLAY (Relay Therapeutics)?

Robert Burns

Which analyst has the most public recommendations on RLAY (Relay Therapeutics)?

Robert Burns works at HC WAINWRIGHT and has 38 price targets and 26 ratings on RLAY

Which analyst is the currently most bullish on RLAY (Relay Therapeutics)?

Priyanka Grover with the highest potential upside of $13.12

Which analyst is the currently most reserved on RLAY (Relay Therapeutics)?

Michael Schmidt with the lowest potential downside of -$8.56
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?